Literature DB >> 4136592

Clindamycin effects on experimental ocular toxoplasmosis in the rabbit.

K F Tabbara, R A Nozik, G R O'Connor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4136592     DOI： 10.1001/archopht.1974.01010010252017

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  11 in total

1.  Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.

Authors:  J Blais; C Tardif; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

3.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Direct immunofluorescence in the diagnosis of toxoplasmic lymphadenitis.

Authors:  R M Matossian; V H Nassar; A Basmadji
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

5.  Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.

Authors:  Nader Baharivand; Ali Mahdavifard; Rohollah Fadaei Fouladi
Journal:  Int Ophthalmol       Date:  2012-09-28       Impact factor: 2.031

6.  Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii.

Authors:  J P Dubey; R A Yeary
Journal:  Can Vet J       Date:  1977-03       Impact factor: 1.008

7.  New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

Authors:  D G Mack; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

Review 8.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 9.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

10.  Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway.

Authors:  Wei Zhou; Juan-Hua Quan; Young-Ha Lee; Dae-Whan Shin; Guang-Ho Cha
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.